Targeted drug tested against chemo for shrinking ovarian tumors before surgery
Disease control
Terminated
This study aimed to see if a targeted drug called niraparib works better than standard chemotherapy to shrink tumors before surgery in people with advanced ovarian cancer that has specific genetic features. It involved 36 participants with newly diagnosed stage III or IV ovarian …
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC